Interacting Drugs |
Rifampin and isoniazid vs CYP2D6 Substrates |
Security Level |
|
Mechanism |
CYP2D6 Substrates: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of CYP2D6 Substrates. Exceptions: Tamoxifen. |
Management |
Monitor therapy |
Rifampin and isoniazid vs CYP2D6 Substrates
Post Review about Rifampin and isoniazid vs CYP2D6 Substrates Click here to cancel reply.
Other Interactions of Rifampin and isoniazid
Other Interactions of CYP2D6 Substrates
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.